Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Fryc

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Biomolecules|July 27, 2024
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus AgentsAgnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
ACS Chemical Neuroscience|June 6, 2025
Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future PerspectivesAnna Czopek, Jakub Jończyk, Monika Fryc, et al.
Neuropharmacology|August 2, 2025
Serotonin 2A (5-HT<sub>2A</sub>) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseasesMonika Fryc, Daria Kluzik, Anna Czopek, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Drug Discovery and Development Targeting DementiaAgnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
Bioorganic Chemistry|July 23, 2023
Synthesis, computational simulations and biological evaluation of new dual 5HT<sub>1A</sub>/5HT<sub>7</sub> receptor ligands based on purine-2,6-dione scaffoldAgnieszka Zagórska, Anna Partyka, Magdalena Jastrzębska-Więsek, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Biomolecules|July 27, 2024
Inhibitors of SARS-CoV-2 Main Protease (Mpro) as Anti-Coronavirus AgentsAgnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
ACS Chemical Neuroscience|June 6, 2025
Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future PerspectivesAnna Czopek, Jakub Jończyk, Monika Fryc, et al.
Neuropharmacology|August 2, 2025
Serotonin 2A (5-HT<sub>2A</sub>) receptor as evolving biological target: function, structure, ligands and role in the therapy of neuropsychiatric diseasesMonika Fryc, Daria Kluzik, Anna Czopek, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Drug Discovery and Development Targeting DementiaAgnieszka Zagórska, Anna Czopek, Monika Fryc, et al.
Bioorganic Chemistry|July 23, 2023
Synthesis, computational simulations and biological evaluation of new dual 5HT<sub>1A</sub>/5HT<sub>7</sub> receptor ligands based on purine-2,6-dione scaffoldAgnieszka Zagórska, Anna Partyka, Magdalena Jastrzębska-Więsek, et al.
Pageof 1